When exploring the landscape of endogenous signaling molecules, the LEAP2 (Liver-expressed antimicrobial peptide 2) structure often stands out due to its unique biochemical properties. As someone deeply interested in the structural biology of peptides, I have spent considerable time analyzing the LEAP2 peptide sequence to better understand its role as a hepatokine and its interaction with physiological receptors.
Structural Composition and The LEAP2 Peptide Sequence
The mature LEAP2 peptide is composed of 40 amino acid residues in humans, which are derived from a larger precursor protein. This precursor is generally understood to consist of a 22-amino-acid signal sequence, a 15-amino-acid prodomain, and the final 40-amino-acid mature protein.
From a biochemical perspective, LEAP2 is a cysteine-rich, and cationic protein. Its structural stability is largely maintained by two disulfide bonds formed by cysteine residues at the 1-3 and 2-4 positions. This specific folding pattern is critical to its functionality. Research into LEAP2 amino acid sequences across various species demonstrates that the LEAP2 peptide sequence is highly conserved from fish to mammals, indicating its fundamental importance in evolutionary biology.
Functional Insights and Inter N‑Terminal Liver-Expressed Antimicrobial Peptide 2 ( actions
Beyond its initial discovery as an expressed antimicrobial peptide 2 (LEAP-2), which functions as part of the innate immune system, this molecule has garnered significant attention for its role in metabolic regulation. Specifically, LEAP2 identified as an endogenous peptide antagonist of the ghrelin receptor (GHS-R1a), effectively modulating the orexigenic signals that typically drive hunger.
In my personal research notes, I often reference the LEAP-2 sequence when comparing it to other regulatory proteins. It is fascinating that LEAP2 is the second liver-expressed antimicrobial peptide discovered, often discussed alongside hepcidin. Furthermore, the LEAP2 peptide is an endogenous pe Fish & Shellfish Immunology ptide with antimicrobial properties that remains stable even when disulfide bonds are reduced, suggesting that the primary sequence holds the key to its binding affinity.
Technical Details and Variations
For those analyzing peptide sequences, it is important to not liver enriched antimicrobial peptide 2 | Ligand page e that LEAP2 is regulated by meal ingestion in both the small intestine and the liver. This dynamic regulation is what makes it a subject of interest in meta Liver-expressed antimicrobial peptide 2. Gene: LEAP2. Status: UniProtKB reviewed (Swiss-Prot). Organism: Homo sapiens (Human). Amino acids: 77 (go to sequence). bolic studies.
Some of the most critical observations include:
* Mature human LEAP2: The standard 40-residue form.
* Fragmental activity: Studies have shown that specific fragments, such as LEAP2 38–47, retain bioactivity, confirming that the N-terminus is crucial for receptor interaction.
* Database Identifiers: When cataloging these sequences, one might encounter the MD5 checksum 19F1187CAD446BA13B0F184AC636B0B4, which serves as a unique fingerprint for the sequence data in bioinformatics repositories.
* Comparative Studies: Whether looking at Ll-LEAP2 or other variants, the consistency in the amino acid composition confirms that the core structure is indispensable for its function as a Leap2 ligand.
Final Thoughts
Whether you are reviewing sequences of the synthesized peptides for laboratory research or simply trying to understand the LEAP2 (Liver Enriched Ant LEAP2 - Liver-expressed antimicrobial peptide 2 imicrobial Peptide 2) mechanism, it is clear that the structural integrity of this molecule is paramount. The high degree of conservation in the LEAP2 peptide sequence underscores its vital role in physiological homeostasis. By focusing on the specific LEAP The dietary regulation of LEAP2 depends on meal -2 residues and their interactions, researchers can continu The dietary regulation of LEAP2 depends on meal e to map the complex pathways involving this fascinating peptide.